Title
Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children
Date Issued
2019
Access level
metadata only access
Resource Type
journal article
Author(s)
Albuquerque V.V.S.
Kumar N.P.
Fukutani K.F.
Vasconcelos B.
Silveira-Mattos P.S.
Babu S.
Andrade B.B.
Instituto Gonçalo Moniz
Publisher(s)
Academic Press
Abstract
The immune profile associated with distinct clinical forms of tuberculosis (TB) has been extensively described for adult populations. Nevertheless, studies describing immune determinants of pulmonary or extrapulmonary TB (PTB or EPTB, respectively) in children are scarce. Here, we retrospectively assessed plasma levels of several mediators of inflammation in age and sex-matched children from South India presenting with PTB (n = 14) or EPTB (n = 22) as well as uninfected healthy controls (n = 19) to identify biomarkers that could accurately distinguish different TB clinical forms. Furthermore, we performed exploratory analyses testing the influence of sex on the systemic inflammatory profile. The analyses identified a biosignature of 10 biomarkers capable of distinguishing the three clinical groups simultaneously. Machine-learning decision trees indicated that C-reactive protein (CRP), matrix metalloproteinase (MMP)-7 and lipopolysaccharide-binding protein (LBP) were the markers that, when combined, displayed the highest accuracy in identifying the clinical groups. Additional exploratory analyses suggested that the disease signatures were highly influenced by sex. Therefore, sex differentially impacted status of systemic inflammation, immune activation and tissue remodeling in children with distinct clinical forms of TB. Regardless of such nuances related to biological sex, MMP-7, CRP and LBP were strong discriminators of active TB and thus could be considered as biomarkers useful in discrimination different TB clinical forms. These observations have implications on our understanding of the immunopathology of both clinical forms of TB in pediatric patients. If validated by other studies in the future, the combination of identified biomarkers may help development of point-of-care diagnostic or prognostic tools.
Volume
123
Language
English
OCDE Knowledge area
Sistema respiratorio
Subjects
Scopus EID
2-s2.0-85068497945
PubMed ID
Source
Cytokine
ISSN of the container
10434666
Sponsor(s)
The authors thank the study participants and their respective families. We would also like to thank Dr. Janani Sankar and Dr. N. Suresh of Child Trust Hospital, Chennai for their assistance in recruiting children for the main study. This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States. NK, SB, BA, PS, KF, MA and VA performed experiments. PM, KF, BA and VA designed experiments. NK, SB, BA, PM, KF and VA provided materials and infrastructural support. BV, MA, PM, VA and BA wrote the manuscript. The authors declare that the research was conducted in the absence of financial and commercial interests, distancing themselves and this research from any conflicts of interest.
This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases , National Institutes of Health , United States.
Sources of information:
Directorio de ProducciĂłn CientĂfica
Scopus